| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.33▲ | 2.32▲ | 2.32▲ | 2.44▼ | 2.39▼ |
| MA10 | 2.32▲ | 2.33▲ | 2.35▼ | 2.51▼ | 2.38▼ |
| MA20 | 2.32▲ | 2.35▼ | 2.38▼ | 2.37▼ | 2.67▼ |
| MA50 | 2.33▲ | 2.43▼ | 2.51▼ | 2.44▼ | 2.63▼ |
| MA100 | 2.36▼ | 2.52▼ | 2.43▼ | 2.71▼ | 2.69▼ |
| MA200 | 2.40▼ | 2.40▼ | 2.35▼ | 2.66▼ | 5.28▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | 0.003▲ | -0.001▼ | 0.004▲ | -0.042▼ |
| RSI | 58.187▲ | 42.968▼ | 40.505▼ | 45.985▼ | 44.902▼ |
| STOCH | 60.000 | 30.564 | 9.140▼ | 41.336 | 32.726 |
| WILL %R | 0.000▲ | -74.194 | -74.194 | -73.729 | -80.319▼ |
| CCI | 147.368▲ | -42.025 | -77.174 | -68.463 | -45.909 |
|
Monday, January 05, 2026 04:18 AM
Program will integrate existing neurocare clinics with HOPE Therapeutics clinics and will engage the already-installed base of 400+ Apollo® ...
|
|
Monday, November 17, 2025 03:50 AM
NRx Pharmaceuticals (NASDAQ: NRXP) reported third-quarter 2025 results and outlined progress across its clinical programs, noting its first revenue-generating activities and key regulatory milestones ...
|
|
Sunday, November 16, 2025 04:00 PM
As of November 17, 2025, the average one-year price target for NRx Pharmaceuticals is $37.23/share. The forecasts range from a low of $25.25 to a high of $49.35. The average price target represents an ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 08/01/26 | 2.43 | 2.445 | 2.29 | 2.33 | 484,995 |
| 07/01/26 | 2.36 | 2.481 | 2.35 | 2.45 | 359,033 |
| 06/01/26 | 2.37 | 2.45 | 2.3301 | 2.39 | 602,187 |
| 05/01/26 | 2.62 | 2.62 | 2.359 | 2.41 | 1,267,059 |
| 02/01/26 | 2.75 | 2.765 | 2.545 | 2.62 | 702,326 |
| 31/12/25 | 2.73 | 2.73 | 2.54 | 2.71 | 620,061 |
| 30/12/25 | 2.58 | 2.65 | 2.56 | 2.63 | 268,705 |
| 29/12/25 | 2.59 | 2.666 | 2.46 | 2.60 | 498,569 |
| 26/12/25 | 2.46 | 2.58 | 2.40 | 2.56 | 499,924 |
| 24/12/25 | 2.37 | 2.46 | 2.34 | 2.44 | 195,393 |
|
|
||||
|
|
||||
|
|